Home Tags IASLC-WCLC

Tag: IASLC-WCLC

Risvutatug Rezetecan Demonstrates Overall Survival Benefit Over Topotecan in Relapsed Small...

Interim results from the pivotal Phase 3 ARTEMIS-008 trial (NCT06498479) show that risvutatug rezetecan, a B7-H3-directed antibody-drug conjugate, significantly reduced the risk of death...